Kinetic profiling an abundantly expressed planarian serotonergic GPCR identifies bromocriptine as a perdurant antagonist

John D. Chan, Thomas Grab, Jonathan S. Marchant

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

The diversity and uniqueness of flatworm G protein coupled receptors (GPCRs) provides impetus for identifying ligands useful as tools for studying flatworm biology, or as therapeutics for treating diseases caused by parasitic flatworm infections. To catalyse this discovery process, technologies optimized for mammalian GPCR high throughput screening need be transposed for screening flatworm GPCRs. Here, we demonstrate the utility of a genetically encoded cAMP biosensor for resolving the properties of an abundantly expressed planarian serotonergic GPCR (S7.1R). Application of this methodology resolved the real time kinetics of GPCR modulation by ligands and demonstrated a marked difference in the kinetic action of antagonists at S7.1R. Notably, bromocriptine caused a protracted inhibition of S7.1R activity in vitro and a protracted paralysis of planarian movement, replicating the effect of S7.1R in vivo RNAi. The lengthy inhibition of function caused by bromocriptine at this abundantly expressed GPCR provides a useful tool to ablate serotonergic signaling in vivo, and is a noteworthy feature for exploitation as an anthelmintic vulnerability.

Original languageEnglish (US)
Pages (from-to)356-363
Number of pages8
JournalInternational Journal for Parasitology: Drugs and Drug Resistance
Volume6
Issue number3
DOIs
StatePublished - Dec 1 2016

Bibliographical note

Funding Information:
This work was supported by the National Science Foundation (MCB1615538).

Keywords

  • 5-HT
  • Ergot alkaloid
  • Flatworm
  • Praziquantel
  • cAMP

Fingerprint Dive into the research topics of 'Kinetic profiling an abundantly expressed planarian serotonergic GPCR identifies bromocriptine as a perdurant antagonist'. Together they form a unique fingerprint.

Cite this